Ropivacaine
- Generic Name
- Ropivacaine
- Brand Names
- Naropin
- Drug Type
- Small Molecule
- Chemical Formula
- C17H26N2O
- CAS Number
- 84057-95-4
- Unique Ingredient Identifier
- 7IO5LYA57N
- Background
Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
- Indication
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
- Associated Conditions
- Acute Pain, Postoperative pain
- Associated Therapies
- Surgical anesthesia therapy
Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study
- First Posted Date
- 2019-05-03
- Last Posted Date
- 2021-04-05
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT03936387
- Locations
- 🇺🇸
Boston Children"S Hospital, Boston, Massachusetts, United States
IPACK Nerve Block for Total Knee Arthroplasty
- First Posted Date
- 2019-04-19
- Last Posted Date
- 2019-04-19
- Lead Sponsor
- Ochsner Health System
- Target Recruit Count
- 72
- Registration Number
- NCT03921034
SERRATHOR TRIAL : Interest of the Novel Serratus Plane Block in Post Operative Analgesia After Video-Assisted Thoracoscopic Lobectomy
- Conditions
- Interventions
- First Posted Date
- 2019-03-08
- Last Posted Date
- 2019-06-04
- Lead Sponsor
- University Hospital, Strasbourg, France
- Target Recruit Count
- 130
- Registration Number
- NCT03867695
- Locations
- 🇫🇷
Les Hôpitaux Universitaires de Strasbourg, Strasbourg, France
Comparing Ropivacaine Adductor Canal Blockade by Surgeon Versus Anesthesiologist
- First Posted Date
- 2019-03-06
- Last Posted Date
- 2019-03-06
- Lead Sponsor
- Rothman Institute Orthopaedics
- Target Recruit Count
- 164
- Registration Number
- NCT03864588
- Locations
- 🇺🇸
Rothman Institute, Philadelphia, Pennsylvania, United States
Incidence of Urethrocutaneous Fistula With and Without Caudal Epidural Block
- Conditions
- Interventions
- First Posted Date
- 2019-01-23
- Last Posted Date
- 2020-10-30
- Lead Sponsor
- Sir Ganga Ram Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT03812731
- Locations
- 🇮🇳
Sir Ganga Ram Hospital, New Delhi, Delhi, India
Analgesic Efficacy of Ropivacaine Alone or in Combination With Adjuvants on Post-operative Analgesia Following Video-Assisted Thoracoscopic Surgery.
- First Posted Date
- 2019-01-18
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Aga Khan University
- Target Recruit Count
- 116
- Registration Number
- NCT03809442
- Locations
- 🇵🇰
Aga Khan University Hospital, Karachi, Sindh, Pakistan
The Erector Spinae Plane Block and Its Effect on Respiratory Status and Pain Management in Rib Fracture Patients
- Conditions
- Interventions
- First Posted Date
- 2019-01-15
- Last Posted Date
- 2020-08-07
- Lead Sponsor
- Virginia Commonwealth University
- Target Recruit Count
- 4
- Registration Number
- NCT03805360
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
The Use of Lumbar Erector Spinae Plane Block for Hip Arthroplasty at the L4 Interspace
- Conditions
- Interventions
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 65
- Registration Number
- NCT03801863
- Locations
- 🇺🇸
Montefiore Medical Center- Wakefield Campus, Bronx, New York, United States
Regional Blocks for Lateral Condyle Fractures
- Conditions
- Interventions
- First Posted Date
- 2019-01-08
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 90
- Registration Number
- NCT03796572
- Locations
- 🇺🇸
Orthopaedic Institute for Children, Los Angeles, California, United States
Continuous Erector Spinae Block Versus Continuous Paravertebral Block
- Conditions
- Interventions
- First Posted Date
- 2018-12-07
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT03768440
- Locations
- 🇺🇸
Boston Children"S Hospital, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.